| scholarly article | Q13442814 |
| P2093 | author name string | S B Calderwood | |
| D W Acheson | |||
| E T Ryan | |||
| J R Butterton | |||
| P2860 | cites work | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 |
| Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development | Q28485732 | ||
| Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype | Q30420490 | ||
| The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins | Q33376042 | ||
| Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection | Q33489524 | ||
| A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience | Q33490973 | ||
| Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects | Q33491823 | ||
| A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells | Q33834748 | ||
| Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection | Q33902441 | ||
| The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model | Q33902492 | ||
| Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems | Q34527617 | ||
| A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens | Q34642972 | ||
| A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit | Q35104239 | ||
| Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II | Q35109009 | ||
| Heterologous antigen expression in Vibrio cholerae vector strains | Q35423953 | ||
| Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells | Q35440445 | ||
| Truncated enterohemorrhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells. | Q35499213 | ||
| Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. | Q36349737 | ||
| An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine | Q36957798 | ||
| Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin | Q36973479 | ||
| Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. | Q36974461 | ||
| Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis. | Q36975350 | ||
| Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli | Q36988590 | ||
| The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid | Q36989598 | ||
| Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector | Q36989608 | ||
| Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies | Q37007284 | ||
| Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. | Q37107796 | ||
| Enzyme-linked immunosorbent assay for shigella toxin. | Q37207255 | ||
| Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae | Q37395794 | ||
| Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive | Q39488888 | ||
| The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. | Q39823009 | ||
| Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. | Q39824053 | ||
| Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity | Q40158183 | ||
| Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery | Q40186741 | ||
| Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. | Q40268887 | ||
| Cloning and nucleotide sequence of the eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7 | Q41506758 | ||
| Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7 | Q41506780 | ||
| An optimized freeze-squeeze method for the recovery of DNA fragments from agarose gels | Q43806909 | ||
| Four die in food poisoning outbreak in Japan | Q43976382 | ||
| M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration | Q45717806 | ||
| Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. | Q54378370 | ||
| Outbreak of E. coli infection in Japan renews concerns. | Q54584929 | ||
| Development of a live, oral, attenuated vaccine against El Tor cholera | Q57924437 | ||
| Carboxy-terminal peptides from the B subunit of Shiga toxin induce a local and parenteral protective effect | Q68538847 | ||
| Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor | Q68930307 | ||
| Duration of infection-derived immunity to cholera | Q70831304 | ||
| Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype | Q72152637 | ||
| Intestinal antibody responses after immunisation with cholera B subunit | Q72520039 | ||
| Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains | Q72746081 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| Vibrio cholerae | Q160821 | ||
| P304 | page(s) | 2127-2135 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains | |
| P478 | volume | 65 |
| Q54424473 | A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2. |
| Q33752525 | A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. |
| Q34004479 | Classical and El Tor biotypes of Vibrio cholerae differ in timing of transcription of tcpPH during growth in inducing conditions |
| Q39108492 | Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies |
| Q46811625 | Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae |
| Q34002734 | Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin |
| Q44320998 | Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli |
| Q34003042 | Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae |
| Q41928379 | Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. |
| Q24533466 | Diarrheagenic Escherichia coli |
| Q82754354 | Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection |
| Q37002887 | Exploiting cholera vaccines as a versatile antigen delivery platform |
| Q64449334 | Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae |
| Q42097551 | Genetic analysis of activation of the Vibrio cholerae Cpx pathway |
| Q33384442 | Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection |
| Q34003489 | In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae |
| Q34000827 | In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae |
| Q36396899 | Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure |
| Q35598035 | Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit |
| Q34003405 | Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains |
| Q35552261 | Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q38998590 | Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins |
| Q34033376 | Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia |
| Q33768681 | Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli |
| Q37301976 | Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermophila |
| Q33504014 | Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity |
| Q42725013 | Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR. |
| Q33995198 | pepA, a gene mediating pH regulation of virulence genes in Vibrio cholerae |
Search more.